Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer
Abstract
Neoadjuvant treatment is standard for locally advanced esophageal cancer. However, whether the addition of radiation to neoadjuvant regimen improves survival remains unclear. The aim of this study was to compare survival in locally advanced esophageal cancer treated with neoadjuvant chemotherapy versus chemoradiation.A prospectively maintained database of esophagectomies (1999-2012) was analyzed. We identified 297 patients with locally advanced...
Paper Details
Title
Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer
Published Date
Aug 1, 2017
Journal
Volume
216
Pages
65 - 72
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History